CBM588
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for CBM588, covering 2024-05-30 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: CBM588 in Improving Clinical Outcomes in Patients Who Have Undergone Donor Hematopoietic Stem Cell Transplant [Phase 1]